In recent years, there have been major advances in the treatment of patients with gynecologic malignancies. Perhaps the biggest advances have been in the area of ovarian cancer. Gynecologic Oncology focuses primarily upon this malignancy.
This volume discusses cytoreductive surgery; screening for ovarian cancer; chemotherapy; new chemotherapeutic drugs; the controversy regarding the role of high-dose chemotherapy in gynecologic cancers; the hereditary basis for gynecologic malignancies; molecular genetics; molecular biology and new biologic therapies.
Other topics covered are the treatment of all stages of cervical cancer, including radiotherapy. In addition, a chapter on advances in the pathology of gynecologic cancers is included.
The advances made in the treatment of gynecologic malignancies are due, in part, to the clinical studies performed by many of the contributors to this volume. Clinical advances have been the result of multidisciplinary approaches which involve molecular biologists, pathologists, radiation therapists, surgeons and chemotherapists. Future advances will continue to rely upon collaborative interaction among these different disciplines.

Keywords

Editors and Affiliations

Fox Chase Cancer Center, Philadelphia, USA

Robert F. Ozols

Bibliographic Information

Book Title: Gynecologic Oncology
Editors: Robert F. Ozols
Series Title: Cancer Treatment and Research
DOI: https://doi.org/10.1007/978-1-4615-5447-9
Publisher: Springer New York, NY
eBook Packages: Springer Book Archive
Copyright Information: Kluwer Academic Publishers 1998
Hardcover ISBN: 978-0-7923-8070-2Published: 30 April 1998
Softcover ISBN: 978-1-4613-7487-9Published: 14 November 2012
eBook ISBN: 978-1-4615-5447-9Published: 14 March 2013
Series ISSN: 0927-3042
Series E-ISSN: 2509-8497
Edition Number: 1
Number of Pages: X, 387
Topics: Oncology

Publish with us

Policies and ethics

Editors:

Sections

Buy it now

Buying options

Other ways to access

Table of contents (12 chapters)

Front Matter

Back Matter

About this book